Malaria

February 23, 2018

Combinatorial therapy for blood-stage Plasmodium infection: A pharmaceutical mixture encompassing Tigecycline (brand name: Tygacil) and Aspirin decreases the expression of CTLA-4, PD-L1 and LAG-3, promotes CD4+ T-cell function, increases secretion of protective antibodies, promotes and clear blood-stage malaria via up regulation of its target gene, 23/February/2018, 6.43 am

Combinatorial therapy for blood-stage Plasmodium infection: A pharmaceutical mixture encompassing Tigecycline (brand name: Tygacil) and Aspirin decreases the expression of CTLA-4, PD-L1 and LAG-3, promotes CD4+ T-cell function, increases secretion of protective antibodies, promotes and clear blood-stage malaria via up regulation of its target gene, 23/February/2018, 6.43 am https://genomediscovery.org/wp-content/uploads/2018/02/Tigecycline-acts-as-an-anti-malarial-agent.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/02/Tigecycline-acts-as-an-anti-malarial-agent.jpg February 23, 2018 February 23, 2018

Introduction: What they say A study from the Department of Microbiology and Immunology, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA shows that “Regulatory T cells impede…

February 16, 2018

Molecular therapy for blood-stage Plasmodium infection: A therapeutic mix encompassing Indinavir and Aspirin decreases the expression of CTLA-4, PD-L1 and LAG-3, promotes CD4+ T-cell function, increases secretion of protective antibodies, promotes and clear blood-stage malaria via up regulation of its target gene, 16/February/2018, 11.45 pm

Molecular therapy for blood-stage Plasmodium infection: A therapeutic mix encompassing Indinavir and Aspirin decreases the expression of CTLA-4, PD-L1 and LAG-3, promotes CD4+ T-cell function, increases secretion of protective antibodies, promotes and clear blood-stage malaria via up regulation of its target gene, 16/February/2018, 11.45 pm https://genomediscovery.org/wp-content/uploads/2018/02/Indinavir-and-Aspirin-inhibit-blood-stage-malaria-through-down-regulation-of-CTLA4-PD1-PDL1-and-LAG3.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/02/Indinavir-and-Aspirin-inhibit-blood-stage-malaria-through-down-regulation-of-CTLA4-PD1-PDL1-and-LAG3.jpg February 16, 2018 February 16, 2018

Introduction: What they say A study from the Department of Microbiology and Immunology, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA shows that “Regulatory T cells impede…

February 14, 2018

Molecular therapy for tuberculosis: Lansoprazole(brand name: Prevacid), a drug used to prevent secretion of acid from stomach and duodenum, deacetylates RelA/p65, inhibits inflammatory gene expression downstream of RelA/p65, inhibits TB pathogenesis, increases the efficacy of anti-TB drug, and promotes M. tuberculosis clearance via up regulation of its target gene, 14/February/2018, 11.58 pm

Molecular therapy for tuberculosis: Lansoprazole(brand name: Prevacid), a drug used to prevent secretion of acid from stomach and duodenum, deacetylates RelA/p65, inhibits inflammatory gene expression downstream of RelA/p65, inhibits TB pathogenesis, increases the efficacy of anti-TB drug, and promotes M. tuberculosis clearance via up regulation of its target gene, 14/February/2018, 11.58 pm https://genomediscovery.org/wp-content/uploads/2018/02/Lansoprazole-protects-against-drug-resistant-Tuberculosis-through-deacetylation-of-p65.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/02/Lansoprazole-protects-against-drug-resistant-Tuberculosis-through-deacetylation-of-p65.jpg February 14, 2018 February 16, 2018

Introduction: What they say: A study from the Singapore Immunology Network, Agency for Science, Technology and Research, Singapore; and Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore shows…

January 25, 2018

Combinatorial therapy for blood-stage Plasmodium infection: A therapeutic mix encompassing Rifampisin (RS) and Aspirin (ASP) (RSASP) decreases the expression of CTLA-4, PD-L1 and LAG-3, promotes CD4+ T-cell function, increases secretion of protective antibodies, promotes and clear blood-stage malaria via up regulation of its target gene, 25/January/2018, 10.41 pm

Combinatorial therapy for blood-stage Plasmodium infection: A therapeutic mix encompassing Rifampisin (RS) and Aspirin (ASP) (RSASP) decreases the expression of CTLA-4, PD-L1 and LAG-3, promotes CD4+ T-cell function, increases secretion of protective antibodies, promotes and clear blood-stage malaria via up regulation of its target gene, 25/January/2018, 10.41 pm https://genomediscovery.org/wp-content/uploads/2018/01/Rifampisin-and-Asprin-inhibit-blood-stage-malaria-through-down-regulation-of-immune-evasion-molecules-including-CTLA-4-PD-1-PD-L1-and-LAG-3.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/01/Rifampisin-and-Asprin-inhibit-blood-stage-malaria-through-down-regulation-of-immune-evasion-molecules-including-CTLA-4-PD-1-PD-L1-and-LAG-3.jpg January 25, 2018 January 25, 2018

Introduction: What they say A study from the Department of Microbiology and Immunology, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA shows that “Regulatory T cells impede…

January 23, 2018

Combinatorial therapy for blood-stage Plasmodium infection: A therapeutic mix encompassing Rilpivirine(RP) and Aspirin (ASP) (RPASP) decreases the expression of CTLA-4, PD-L1 and LAG-3, promotes CD4+ T-cell function, increases secretion of protective antibodies, promotes and clear blood-stage malaria via up regulation of its target gene, 23/January/2018, 11.51 pm

Combinatorial therapy for blood-stage Plasmodium infection: A therapeutic mix encompassing Rilpivirine(RP) and Aspirin (ASP) (RPASP) decreases the expression of CTLA-4, PD-L1 and LAG-3, promotes CD4+ T-cell function, increases secretion of protective antibodies, promotes and clear blood-stage malaria via up regulation of its target gene, 23/January/2018, 11.51 pm https://genomediscovery.org/wp-content/uploads/2018/01/Rilpivirine-and-Asprin-inhibit-blood-stage-malaria-through-down-regulation-of-immune-evasion-molecules-including-CTLA-4-PD-1-PD-L1-and-LAG-3.jpg2_.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/01/Rilpivirine-and-Asprin-inhibit-blood-stage-malaria-through-down-regulation-of-immune-evasion-molecules-including-CTLA-4-PD-1-PD-L1-and-LAG-3.jpg2_.jpg January 23, 2018 January 23, 2018

Introduction: What they say A study from the Department of Microbiology and Immunology, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA shows that “Regulatory T cells impede…

January 19, 2018

Natural product-derived therapy for blood-stage Plasmodium infection: Fisetin, isolated from A. greggi , A. berlanderi, strawberry among others, decreases the expression of CTLA-4, PD-L1 and LAG-3, promotes CD4+ T-cell function, increases secretion of protective antibodies, promotes and clear blood-stage malaria via up regulation of its target gene, 19/January/2018, 10.41 am

Natural product-derived therapy for blood-stage Plasmodium infection: Fisetin, isolated from A. greggi , A. berlanderi, strawberry among others, decreases the expression of CTLA-4, PD-L1 and LAG-3, promotes CD4+ T-cell function, increases secretion of protective antibodies, promotes and clear blood-stage malaria via up regulation of its target gene, 19/January/2018, 10.41 am https://genomediscovery.org/wp-content/uploads/2018/01/Fisetin-inhibits-blood-stage-malaria-through-down-regulation-of-immune-evasion-molecules-including-CTLA-4-PD-1-PD-L1-and-LAG-31.jpg 960 720 Dr Boomi's Genom-2-Discovery Center Dr Boomi's Genom-2-Discovery Center https://genomediscovery.org/wp-content/uploads/2018/01/Fisetin-inhibits-blood-stage-malaria-through-down-regulation-of-immune-evasion-molecules-including-CTLA-4-PD-1-PD-L1-and-LAG-31.jpg January 19, 2018 January 19, 2018

Introduction: What they say A study from the Department of Microbiology and Immunology, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA shows that “Regulatory T cells impede…

Popular Post